406 related articles for article (PubMed ID: 15794927)
21. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis.
Fazzalari NL; Kuliwaba JS; Atkins GJ; Forwood MR; Findlay DM
J Bone Miner Res; 2001 Jun; 16(6):1015-27. PubMed ID: 11393778
[TBL] [Abstract][Full Text] [Related]
22. Fluid flow induces Rankl expression in primary murine calvarial osteoblasts.
Mehrotra M; Saegusa M; Wadhwa S; Voznesensky O; Peterson D; Pilbeam C
J Cell Biochem; 2006 Aug; 98(5):1271-83. PubMed ID: 16514640
[TBL] [Abstract][Full Text] [Related]
23. Areca nut extracts modulated expression of alkaline phosphatase and receptor activator of nuclear factor kappaB ligand in osteoblasts.
Ling LJ; Ho FC; Chen YT; Holborow DW; Liu TY; Hung SL
J Clin Periodontol; 2005 Apr; 32(4):353-9. PubMed ID: 15811051
[TBL] [Abstract][Full Text] [Related]
24. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
[TBL] [Abstract][Full Text] [Related]
25. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin.
Bock O; Loch G; Schade U; Büsche G; Wasielewski R; Wiese B; Kreipe H
Br J Haematol; 2005 Jul; 130(1):76-82. PubMed ID: 15982347
[TBL] [Abstract][Full Text] [Related]
26. Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like cells.
Maddi A; Hai H; Ong ST; Sharp L; Harris M; Meghji S
Bone; 2006 Aug; 39(2):283-8. PubMed ID: 16567138
[TBL] [Abstract][Full Text] [Related]
27. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
28. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP
J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667
[TBL] [Abstract][Full Text] [Related]
30. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
[TBL] [Abstract][Full Text] [Related]
31. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas.
Menezes R; Bramante CM; da Silva Paiva KB; Letra A; Carneiro E; Fernando Zambuzzi W; Granjeiro JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):404-9. PubMed ID: 16920551
[TBL] [Abstract][Full Text] [Related]
32. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
[TBL] [Abstract][Full Text] [Related]
34. Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells.
Zahanich I; Graf EM; Heubach JF; Hempel U; Boxberger S; Ravens U
J Bone Miner Res; 2005 Sep; 20(9):1637-46. PubMed ID: 16059635
[TBL] [Abstract][Full Text] [Related]
35. PTH differentially regulates expression of RANKL and OPG.
Huang JC; Sakata T; Pfleger LL; Bencsik M; Halloran BP; Bikle DD; Nissenson RA
J Bone Miner Res; 2004 Feb; 19(2):235-44. PubMed ID: 14969393
[TBL] [Abstract][Full Text] [Related]
36. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.
Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ
J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187
[TBL] [Abstract][Full Text] [Related]
37. Osteoprotegerin is expressed in colon carcinoma cells.
Pettersen I; Bakkelund W; Smedsrød B; Sveinbjørnsson B
Anticancer Res; 2005; 25(6B):3809-16. PubMed ID: 16309167
[TBL] [Abstract][Full Text] [Related]
38. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone.
Roux S; Amazit L; Meduri G; Guiochon-Mantel A; Milgrom E; Mariette X
Am J Clin Pathol; 2002 Feb; 117(2):210-6. PubMed ID: 11863217
[TBL] [Abstract][Full Text] [Related]
39. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
40. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA.
Baumann B; Rader CP; Seufert J; Nöth U; Rolf O; Eulert J; Jakob F
Acta Orthop Scand; 2004 Jun; 75(3):295-302. PubMed ID: 15260421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
